Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Emcure Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:544210NSE Symbol: EMCUREP/E(TTM):76.72
ISIN Demat:INE168P01015Div & Yield %:0.23EPS(TTM):16.73
Book Value(Rs):159.5913001Market Cap ( Cr.):24324.34Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 3497.663107.093387.243107.412375.712453.70
Excise Duty0.000.000.000.000.000.00
Net Sales3497.663107.093387.243107.412375.712453.70
Other Income 138.26125.35132.6896.52137.6290.88
Stock Adjustments 101.70-14.4536.10107.96-59.70-14.71
Total Income3737.623217.993556.023311.892453.632529.87
EXPENDITURE :      
Raw Materials 1464.671199.251354.991345.85751.46730.09
Power & Fuel Cost88.7380.4172.4673.5167.2961.44
Employee Cost 706.41649.18603.95543.92545.35516.14
Other Manufacturing Expenses 209.89192.67219.39198.00127.43186.81
Selling and Administration Expenses 532.87443.20263.11226.17342.04279.22
Miscellaneous Expenses 164.2295.59114.7894.06103.18129.84
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure3166.782660.302628.672481.511936.751903.54
Operating Profit570.83557.69927.36830.39516.88626.33
Interest 166.09166.83145.14118.28137.22126.65
Gross Profit404.74390.86782.22712.11379.66499.68
Depreciation204.83178.52165.79154.21154.97129.84
Profit Before Tax199.91212.34616.43557.90224.69369.84
Tax38.5853.10168.72141.6572.8191.35
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.50-0.830.89-4.23-23.34-5.17
Reported Net Profit160.83160.06446.81420.48175.21283.65
Extraordinary Items -1.64-4.800.10-2.90-32.65-26.32
Adjusted Net Profit162.47164.86446.71423.38207.86309.97
Adjst. below Net Profit -5.344.06-0.790.11-2.030.11
P & L Balance brought forward1593.841465.891877.111474.611349.71989.73
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 54.2636.17857.2418.0948.27-76.22
P & L Balance carried down1695.081593.841465.891877.111474.611349.71
Dividend0.000.0036.170.000.0045.21
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %20.0020.0030.0010.0025.0025.00
Earnings Per Share-Unit Curr8.888.8524.7123.259.6915.68
Earnings Per Share(Adj)-Unit CurrNANANANANANA
Book Value-Unit Curr106.82101.8494.69127.27105.8698.29